- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- Prospects for cannabinoid therapies in basal ganglia disorders
- Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movementsleep behaviour disorder in Parkinson’s disease patients
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease
- Therapeutic potential of cannabinoids in CNS disease
- CB2 Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease